Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE: 002399)
China flag China · Delayed Price · Currency is CNY
9.84
0.00 (0.00%)
Sep 9, 2024, 1:35 PM CST

Shenzhen Hepalink Pharmaceutical Group Revenue

Shenzhen Hepalink Pharmaceutical Group had revenue of 1.46B CNY in the quarter ending June 30, 2024, with 3.70% growth. This brings the company's revenue in the last twelve months to 5.57B, down -8.89% year-over-year. In the year 2023, Shenzhen Hepalink Pharmaceutical Group had annual revenue of 5.45B, down -23.94%.

Revenue (ttm)
5.57B
Revenue Growth
-8.89%
P/S Ratio
2.57
Revenue / Employee
2.68M
Employees
2,080
Market Cap
12.86B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.45B-1.71B-23.94%
Jan 1, 20237.16B794.23M12.48%
Jan 1, 20226.37B1.03B19.38%
Dec 31, 20205.33B707.42M15.30%
Dec 31, 20194.62B-190.31M-3.95%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition